About
Basic Data Updated:
13 days agoMedicamen Biotech Limited is involved in the production, development, and distribution of pharmaceutical formulations. These formulations are primarily composed of betalactum, non-betalactum, and cephalosporin drugs. The company offers a wide range of products, including tablets, capsules, syrup, dry syrup, ointment, and ORS. It has been certified with ISO 9001:2008. The company has established partnerships with distributors and importers in various regions such as Africa, Central America, Brazil, and South East Asia to effectively market its products. The manufacturing facilities of MBL are situated in Bhiwadi, Rajasthan, and Haridwar, Uttarakhand. The Bhiwadi facility spans over an area of 210,000 sq ft, while the Haridwar facility covers 32,000 sq ft.
Industry
Company Details
- Location
South Delhi, Delhi, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Financials of Medicamen Biotech Limited
Medicamen Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.78% increase. The company also saw a slight improvement in profitability, with a 0.64% increase in profit. The company's net worth Soared by an impressive increase of 30.91%.
Enhance accessibility to Medicamen Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Medicamen Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Medicamen Biotech Limited
Unlock and access historical data on people associated with Medicamen Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
RM
Rajesh Madan CEOStatus: Current
PR
Pratap Rawat CFOStatus: Current
PC
Parul Choudhary Company SecretaryStatus: Current
Board Members(10)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 10 May 2023 | ₹3.50 M | Open |
Citi Bank N.A. Creation Date: 19 Mar 2021 | ₹20.00 Cr | Open |
Others Creation Date: 30 Jan 2021 | ₹1.20 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicamen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicamen Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Shivalik Rasayan Limited
Active 45 years 1 monthSanjay Bansal, Rahul Bishnoi and 8 more are mutual person
Medicamen Life Sciences Private Limited
Active 1 year 8 monthsRahul Bishnoi and Ashwani Sharma are mutual person
Recent activity within the organization
Charges
A charge with Citi Bank N.A. of Rs. 20.00 cr registered on 19 Mar 2021 with Charge ID 100449354 was modified on 17 Nov 2023.
17 Nov 2023Annual General Meeting
Medicamen Biotech Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
27 Sep 2023Charges
A charge registered on 02 Jul 2015 via Charge ID 10587692 with Indian Bank was fully satisfied on 23 Jun 2023.
23 Jun 2023Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.35 cr with Charge ID 100755628 was registered on 10 May 2023.
10 May 2023Balance Sheet
Medicamen Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023
Recent News, Updates & Announcement
- Global Folic Acid Market 20182022 with BASF Emcure Pharmaceuticals Medicamen Biotech Nantong Changhai Food Additive amp Royal DSM Dominating.
PRNewswire The quotGlobal Folic Acid Market 20182022quot report has been added to ResearchAndMarketscoms offering The Global Folic Acid Market to grow at a.
PR Newswire 03 Oct 2018
Frequently asked questions
What is the Incorporation or founding date of Medicamen Biotech Limited?